financetom
Business
financetom
/
Business
/
Delek US Q3 revenue beats expectations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Delek US Q3 revenue beats expectations
Nov 7, 2025 3:55 AM

Overview

* Delek US ( DK ) Q3 revenue beats expectations, driven by Small Refinery Exemptions

* Company increases annual cash flow improvement guidance to at least $180 mln

Outlook

* Delek US ( DK ) expects ~$400 mln in proceeds from SRE monetization over next 6-9 months

* Company raises annual cash flow improvement guidance to at least $180 mln

* Delek Logistics raises full-year adjusted EBITDA guidance to $500-$520 mln

Result Drivers

* SRE IMPACT - Co recognized a $280.8 mln benefit from Small Refinery Exemptions granted by the EPA, reducing costs significantly

* LOGISTICS GROWTH - Logistics segment growth driven by W2W dropdown and H2O Midstream and Gravity Acquisitions

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $2.89 $2.76

Revenue bln bln (8

Analysts

)

Q3 $7.13

Adjusted

EPS

Q3 EPS $2.93

Q3 $434.20

Adjusted mln

Net

Income

Q3 Net $178 mln

Income

Q3 $759.60

Adjusted mln

EBITDA

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy", 9 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the oil & gas refining and marketing peer group is "buy."

* Wall Street's median 12-month price target for Delek US Holdings Inc ( DK ) is $34.00, about 15.3% below its November 6 closing price of $39.21

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alphabet's YouTube Trails TikTok in Global Video Revenue, Omdia Says
Alphabet's YouTube Trails TikTok in Global Video Revenue, Omdia Says
Jan 21, 2025
10:25 AM EST, 01/21/2025 (MT Newswires) -- Alphabet's (GOOG, GOOGL) YouTube ( GOOG ) had a global advertising revenue of $33.3 billion in 2024 compared with TikTok's global video revenues of $63.3 billion, Omdia reported Tuesday. In 2024, TikTok crossed 1.9 billion monthly active users globally, including 145 million monthly active users in the US, with about $8 billion advertising...
Why InMed Pharmaceuticals (INM) Stock Is Skyrocketing
Why InMed Pharmaceuticals (INM) Stock Is Skyrocketing
Jan 21, 2025
InMed Pharmaceuticals Inc ( INM ) shares are trading higher by 22.6% to $6.05 during Tuesday’s session after the company announced that INM-901 reduced Alzheimer’s-related inflammation in a preclinical study. What To Know: The study revealed a significant reduction in markers of neuroinflammation, a key driver of Alzheimer's progression. Treatment with INM-901 led to a dose-dependent decrease in pro-inflammatory cytokines...
Guardant Health Gets Medicare Coverage for Guardant Reveal in CRC Surveillance Testing
Guardant Health Gets Medicare Coverage for Guardant Reveal in CRC Surveillance Testing
Jan 21, 2025
10:26 AM EST, 01/21/2025 (MT Newswires) -- Guardant Health ( GH ) said Tuesday that Palmetto GBA has granted coverage for the Guardant Reveal test to monitor for disease recurrence in colorectal cancer patients after curative intent therapy, expanding from the prior coverage in the early post-surgical setting only. Palmetto is a Medicare administrative contractor that administers the Molecular Diagnostics...
What's Going On With Palantir Stock Tuesday?
What's Going On With Palantir Stock Tuesday?
Jan 21, 2025
Palantir Technologies Inc ( PLTR ) shares are trading higher on Tuesday. Here’s a look at what’s going on. What To Know: Palantir ( PLTR ) shares are getting a lift in early trading. It’s possible that buyers are stepping in after U.S. President Donald Trump revoked an executive order from 2023 that aimed to reduce the risks of AI...
Copyright 2023-2026 - www.financetom.com All Rights Reserved